Enhanced Early Innate and T Cell-mediated Responses in Subjects Immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)

NuThrax(™) (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant) (AV7909) is in development. Samples obtained in a Phase Ib clinical trial were tested to confirm biomarkers of innate immunity and evaluate effects of CPG 7909 (PF-03512676) on adaptive immunity. Subjects received two intramuscular doses o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Minang, Jacob T., Inglefield, Jon R., Harris, Andrea M., Lathey, Janet L., Alleva, David G., Sweeney, Diane L., Hopkins, Robert J, Lacy, Michael J., Bernton, Edward W.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4133324/
https://ncbi.nlm.nih.gov/pubmed/24530403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.01.096
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia